(Q72676234)

English

Association between HLA B7,DR2 and dysfunction of natural- and antibody- mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis

scientific article published on 01 June 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Association between HLA B7,DR2 and dysfunction of natural- and antibody- mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis (English)

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

multiple sclerosis

1 reference

based on heuristic

inferred from title

immunologic cytotoxicity

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

antibody-dependent cellular cytotoxicity

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

author name string

E. Gyódi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

M. Benczur

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

G. Pálffy

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

M. Tálas

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

G. Petrányi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

I. Földes

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

S. R. Hollán

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181031

22 August 2023

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6181031

22 August 2023

publication date

1 June 1982

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

full work available at URL

https://api.elsevier.com/content/article/PII:0198885982900362?httpAccept=text/xml

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

https://api.elsevier.com/content/article/PII:0198885982900362?httpAccept=text/plain

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Human Immunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

209-217

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis

1

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Measles virus in jejunum of patients with multiple sclerosis

2

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Immunological changes in multiple sclerosis

3

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

The significance of the association between HLA and multiple sclerosis

4

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains

5

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

MEASLES ANTIBODIES IN MULTIPLE SCLEROSIS

6

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Rickettsial and viral antibodies in multiple sclerosis.

7

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

INFECTIVE AGENTS AND MULTIPLE SCLEROSIS

8

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Lymphocyte stimulation with measles antigen in multiple sclerosis

9

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Effect of phytohemagglutinin, basic protein and measles antigen on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes from patients with multiple sclerosis

10

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Decreased lymphocyte transformation to vaccinia virus in multiple sclerosis

11

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies

12

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor

15

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Is multiple sclerosis an age-dependent host response to measles?

17

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Isolation of B and T Lymphocytes by Nylon Fiber Columns

23

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis

25

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

26

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Human peripheral null lymphocytes II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus andCorynebacterium parvum

28

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Mechanisms of Activation of Human Natural Killer Cells Against Tumor and Virus-infected Cells

29

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

30

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Interferon as a mediator of human lymphocyte suppression

31

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection

32

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

The HLA antigen distribution in the Gipsy population in Hungary

34

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Letter: HL-A 3,7 and lymphocyte cytotoxic activity

36

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

A family of structural genes for human lymphoblastoid (leukocyte-type) interferon

38

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

The structure of one of the eight or more distinct chromosomal genes for human interferon-α

39

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Increased frequency of HLA-DRW2 in SLE

40

1 reference

10.1016/0198-8859(82)90036-2

https://api.crossref.org/works/10.1016/0198-8859(82)90036-2

22 August 2023

Identifiers

10.1016/0198-8859(82)90036-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181031%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72676234&oldid=1958803424"